MELIOR DISCOVERY is Pioneering High Throughput Pharmacology as a Uniquely Productive Drug Discovery Strategy. Melior Discovery has developed the theraTRACE® indications discovery platform of multiplexed in vivo disease models to uncover new indications for existing pharmaceutical compounds. TheraTRACE® combines up to 52 in vivo models in a way that allows scientists to test a compound for its potential efficacy across a broad array of therapeutic areas. Visit www.meliordiscovery.com and www.meliorpharmaceuticals.com